TSX News -
Fairfax Financial Holdings Limited: Personnel Announcement
TORONTO, June 04, 2024 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) is pleased to announce […]
Methanex Corporation Provides Update on Egypt Operations
VANCOUVER, British Columbia, June 04, 2024 (GLOBE NEWSWIRE) — Methanex Corporation (TSX:MX) (NASDAQ:MEOH) announced today that its 1.26 million tonne […]
TC Energy shareholders approve spinoff of South Bow and elect Board of Directors at the 2024 annual and special meeting
CALGARY, Alberta, June 04, 2024 (GLOBE NEWSWIRE) — News Release – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or […]
TSX News -
Savaria Announces Appointment of New Board Member
LAVAL, Québec, June 04, 2024 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS) a global leader in the accessibility industry, […]
Gentherm Receives First Production Vehicle Award for its Puls.A™ Technology
NORTHVILLE, Mich., June 04, 2024 (GLOBE NEWSWIRE) — Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic […]
NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders
TORONTO and HAIFA, Israel, June 04, 2024 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the […]
Vision Sensing Acquisition Corp. Announces Receipt of a Deficiency Notice from Nasdaq for Failure to Timely File its 1st Quarter 2024 Form 10-Q and Announces the Filing of the Form 10-Q
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special […]
Lifeward to Present at Sidoti Virtual Investor Conference on June 12
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 04, 2024 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the […]
Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
Information regarding the total number of voting rights andtotal number of shares of the Company as of May 31, 2024 […]
Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology […]
